Figure 9.

Prognostic significance of Riskscore in LGGs stratified by clinical features. (A-H) According to FAMR, the patients in the G2 group (A), the patients in the G3 group (B), the patients in the female group (C), the patients in the male group (D), patients aged ≥ 60 groups (E), patients aged < 60 groups (F), patients in IDH WT group (G) and patients in IDH mutation group (H) were divided into two groups with significant prognosis. (I) FAMR in G2 and G3 of LGGs. (J) FAMR in IDH WT group and IDH mutation group of LGGs.